NON-INTRINSIC CANCER RISK FACTORS
Özet
Our knowledge about the etiology of cancer is increasing. Many studies show that non-intrinsic factors such as environment or lifestyle are the main risk factors for the occurrence of cancer. On the other hand, there are studies showing that the main risk factors in the occurrence of cancer are caused by DNA replication errors (known as the intrinsic factors). This view limits highly the possibility of protection from cancer. However, the findings obtained from the literature show that non-intrinsic factors contribute substantially to cancer risk and that cancer should be considered as a preventable disease. This review is aimed to examine the factors known as non-intrinsic cancer risk factors in the light of recent research. Copyright © Experimental Oncology, 2021
Cilt
43Sayı
4Bağlantı
https://doi.org/10.32471/EXP-ONCOLOGY.2312-8852.VOL-43-NO-4.16804http://hdl.handle.net/11446/4632
Koleksiyonlar
İlgili Öğeler
Başlık, yazar, küratör ve konuya göre gösterilen ilgili öğeler.
-
Mesenchymal stem cells have ameliorative effect on the colitis model via Nrf2/HO-1 pathway
Bozkurt, M.F.; Bhaya, M.N.; Dibekoğlu, C.; Akat, A.; Ateş, U.; Erbaş, O. (Sociedade Brasileira para o Desenvolvimento de Pesquisa em Cirurgia, 2022)Purpose: To evaluate the ameliorative effect of mesenchymal stem cells (MSCs) on acetic acid colitis model via Nrf2/HO-1 pathway in rats. Methods: In this study, 30 rats were divided into three groups. Acute colitis was ... -
Investigation of the protective effects of dichloroacetic acid in a rat model of diabetic neuropathy
Ari, Murat; Erdogan, Mumin Alper; Erbaş, Oytun (BioMed Central Ltd, 2025)Background: Diabetic neuropathy (DN) is a heterogeneous condition characterized by complex pathophysiological changes affecting both autonomic and somatic components of the nervous system. Inflammation and oxidative stress ... -
One-Third of European Patients With Axial Spondyloarthritis Reach Pain Remission With Routine Care Tumor Necrosis Factor Inhibitor Treatment
Ørnbjerg L.M.; Rugbjerg K.; Georgiadis S.; Rasmussen S.H.; Lindström U.; Pavelka K.; Yilmaz N. (Journal of Rheumatology, 2023)Objective. To investigate the distribution of patient-reported outcomes (PROs) in patients with axial spondyloarthritis (axSpA) initiating a tumor necrosis factor inhibitor (TNFi), to assess the proportion reaching PRO ...